240 filings
Page 3 of 12
8-K
7sy8ksy73wkds81yew
1 Nov 22
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
4:05pm
8-K
5vjqh8n1
27 Oct 22
CRISPR Therapeutics Announces Planned Transition of Chief Operating Officer
8:36am
8-K
9es46xdpk1uf4om6f0m5
27 Sep 22
Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022
7:48am
S-8
yo8rqouuw
8 Aug 22
Registration of securities for employees
4:06pm
8-K
8qkk oco06spyz5mk67
8 Aug 22
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
8:05am
CORRESP
jeo647wcae8i 5z4f
23 Jun 22
Correspondence with SEC
12:00am
8-K
f1911t
21 Jun 22
Other Events
5:05pm
8-K
1rbeplqb84o4d8pjzz2
13 Jun 22
Departure of Directors or Certain Officers
4:58pm
8-K
179n3ct
13 Jun 22
Regulation FD Disclosure
8:02am
UPLOAD
ng91ah
13 Jun 22
Letter from SEC
12:00am
8-K
s97sk2 sluu
16 May 22
CRISPR Therapeutics Announces the Appointment of Phuong Khanh Morrow, M.D., FACP, as Chief Medical Officer
4:14pm
8-K
3dwhomz0q7q sqk
12 May 22
Regulation FD Disclosure
4:05pm
8-K
i6cyoho uo6e
9 May 22
Results of Operations and Financial Condition
4:06pm
DEFA14A
3sl0zc10 n9mq6ht1j3
25 Apr 22
Additional proxy soliciting materials
4:27pm
8-K
jik7nu
15 Feb 22
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:05pm